Primary Hyperoxaluria Type 1 — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Primary hyperoxaluria
Massively elevated urine and plasma oxalate with AGXT mutation is primary hyperoxaluria type 1 (PH1) — an autosomal recessive disorder causing hepatic overproduction of oxalate. It causes nephrocalcinosis, CKD, and systemic oxalosis. Lumasiran (RNA interference therapy targeting HAO1) reduces oxalate production and is now approved. Pyridoxine (B6) is first-line for B6-responsive PH1 (30-50% of cases). Liver-kidney transplant for ESKD.
Reference: KDIGO – 2024; ERA PH1 Guidelines 2024